Latest Migraine surgery Stories
Roughly 15% of children suffer from migraines, and approximately one-third of these affected children have migraines with aura, a collection of symptoms that can include weakness, blind spots, and even hallucinations. Although the causes of migraines are unclear, a new study soon to be published in The Journal of Pediatrics suggests a connection between migraine headaches in children and a heart defect called patent foramen ovale, which affects 25% of people in the U.S.Dr. Rachel McCandless...
(Ivanhoe Newswire) -- Bariatric surgery may provide an added benefit to severely obese patients besides weight loss: it can also help alleviate the excruciating pain of migraine headaches, according to this study.Researchers say obese patients who had suffered painful and debilitating migraines before bariatric surgery reported improvements in headache frequency, severity and disability just six months after surgery. At that point, most patients had lost an average of 66.4...
Neurofeedback More Effective than Medication: Eliminates Headaches Without Side-Effects. Stunning results from a new study reveal that 54% of participants receiving neurofeedback experienced complete relief from migraines. Beachwood, OH (PRWEB) March 15, 2011 Migraines cost American taxpayers $13 billion in missed work or reduced productivity annually. In a time of job insecurity and financial vulnerability, when stress levels are high and incomes are low, crippling migraines are an...
A new study, published in the journal Headache, has found that girls who get migraines appear more likely than their peers to gain extra weight during adulthood. Reuters reports that scientists found that four in ten women with childhood migraines had added at least 22 pounds since age 18, compared to three in ten women who never had the excruciating headaches. Other studies have linked migraines to obesity, but the new results held up even after taking into consideration that children...
SILVER SPRING, Md., Oct. 15 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine is defined as having a history of migraine and experiencing a headache on most days of the month. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) "Chronic migraine is one of the most disabling...
Ohio University-led study suggests new option for headache pain managementThe combination of preventive medication and behavioral changes offered significant relief for 77 percent of the individuals enrolled in a study aimed at combating frequent, disabling migraine headaches, according to new Ohio University research published this week in the British Medical Journal.Though daily preventive medication and behavioral techniques individually have been shown to improve headache pain, the new...
Psychological migraine treatment gives sufferers a confidence boost in their ability to self-manage their symptomsFor severe migraine sufferers, psychological treatments build on the benefits of drug therapy, according to a new study1 by Elizabeth Seng and Dr. Kenneth Holroyd from Ohio University in the US. Their comparison of the effects of various treatment combinations for severe migraine "“ drug therapy with or without behavioral management "“ shows that those patients receiving the...
A preliminary study suggests the same type of botulinum injection used for cosmetic purposes may be associated with reduced frequency of migraine headaches that are described as crushing, vicelike or eye-popping (ocular), but not pain that is experienced as a buildup of pressure inside the head, according to a report in the February issue of Archives of Dermatology, one of the JAMA/Archives journals.Migraine headaches affect approximately 28 million Americans, causing pain that is often...
MOUNTAIN VIEW, Calif., Oct. 29 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that it has completed a planned interim safety review of the open-label, long-term safety extension of the company's Phase 3 FREEDOM 301 clinical trial with its LEVADEX(TM) orally inhaled migraine therapy. To date, more than 400 patients have completed at least six months of treatment and over 7,800 headaches have been treated in the safety extension. No drug-related serious...
The disability from migraine headaches is an enormous health burden affecting over 30 million Americans.In newly released research, 79 migraine sufferers were followed for at least five years after having undergone detection of migraine "trigger sites" and surgery. The new data finds promising outcomes for treating trigger sites surgically for migraine headaches resulting in elimination of pain for those afflicted with the condition.Since the surgery, 10 of the 79 patients required...
